A new approach to modulating the extracellular metabolites of biofilm cells to enhance the ability of antimicrobial agents

About

This technology utilizes a new approach to modulating the extracellular metabolites of biofilm cells to enhance the ability of antimicrobial agents and/or the immune system to control the growth and persistence of microorganisms in medical settings and aqueous systems.

RB567

Key Benefits

(1) Biodegradable. (2) Non-toxic. (3) Approach capable of targeting resistant biofilm cells. (4) Mechanism of action and experimental data suggest very low likelihood of the emergence of resistance. (5) Can be used synergistically with other antimicrobials and dispersion-inducing compounds.

Applications

Targeting chronic biofilm infections.
Disinfection of bacterial biofilms on surfaces.

Purchase a license for full unlimited access to all innovation profiles on LEO

  • Direct connection to thousands of more innovations
  • Access to market Experts and Universities
  • Filter relevant solutions into your own dedicated Network